Insider Transactions Reported by 13 Insiders of PUMA BIOTECHNOLOGY, INC.

Symbol
PBYI on Nasdaq
Location
Los Angeles, CA

Insiders trading volume in the past year

PUMA BIOTECHNOLOGY, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
ALAN H. AUERBACH President and CEO, Director, 10%+ Owner $25,384,485 -$166,702 -0.65% 08 Jul 2025
MAXIMO F. NOUGUES Chief Financial Officer $721,949 -$33,649 -4.5% 08 Jul 2025
Alvin F. Wong Chief Scientific Officer $633,593 12 Feb 2024
DOUGLAS M. HUNT The Reporting Person is the Senior Vice President of Regulatory Affairs of the Issuer. $582,900 -$27,624 -4.5% 08 Jul 2025
Jeffrey Jerome Ludwig Chief Commercial Officer $494,161 07 Feb 2025
Brian M. Stuglik Director $321,907 -$27,459 -7.9% 13 Jun 2025
MICHAEL PATRICK MILLER Director $262,515 -$97,228 -27% 11 Nov 2025
Allison Dorval Director $256,326 -$39,474 -13% 13 Jun 2025
Ann C. Miller Director $182,720 15 Jun 2021
JAY M. MOYES Director $181,294 -$74,800 -29% 13 Jun 2025
TROY E. WILSON Director $150,066 -$36,720 -20% 13 Jun 2025
Alessandra Cesano Director $140,908 -$132,219 -48% 18 Jul 2025
Adrian Senderowicz Director $91,800 -$91,800 -50% 13 Jun 2025

Recent Insider Transactions by Companies or Individuals for PUMA BIOTECHNOLOGY, INC.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.